Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vivos Therapeutics (VVOS) Change in Receivables (2020 - 2025)

Vivos Therapeutics has reported Change in Receivables over the past 6 years, most recently at -$553000.0 for Q4 2025.

  • Quarterly Change in Receivables fell 2204.17% to -$553000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $217000.0 through Dec 2025, down 4.82% year-over-year, with the annual reading at $217000.0 for FY2025, 4.82% down from the prior year.
  • Change in Receivables was -$553000.0 for Q4 2025 at Vivos Therapeutics, down from $501000.0 in the prior quarter.
  • Over five years, Change in Receivables peaked at $1.8 million in Q2 2021 and troughed at -$2.6 million in Q4 2021.
  • The 5-year median for Change in Receivables is -$21500.0 (2024), against an average of -$39200.0.
  • Year-over-year, Change in Receivables surged 4626.55% in 2021 and then tumbled 2283.33% in 2024.
  • A 5-year view of Change in Receivables shows it stood at -$2.6 million in 2021, then surged by 84.45% to -$409000.0 in 2022, then skyrocketed by 93.64% to -$26000.0 in 2023, then increased by 7.69% to -$24000.0 in 2024, then crashed by 2204.17% to -$553000.0 in 2025.
  • Per Business Quant, the three most recent readings for VVOS's Change in Receivables are -$553000.0 (Q4 2025), $501000.0 (Q3 2025), and -$19000.0 (Q2 2025).